PE20100443A1 - DERIVATIVES OF PHENYL-CARBONYL-AMINO-PROPANOIC ACID AS ANTAGONISTS OF GLUCAGON - Google Patents
DERIVATIVES OF PHENYL-CARBONYL-AMINO-PROPANOIC ACID AS ANTAGONISTS OF GLUCAGONInfo
- Publication number
- PE20100443A1 PE20100443A1 PE2009001096A PE2009001096A PE20100443A1 PE 20100443 A1 PE20100443 A1 PE 20100443A1 PE 2009001096 A PE2009001096 A PE 2009001096A PE 2009001096 A PE2009001096 A PE 2009001096A PE 20100443 A1 PE20100443 A1 PE 20100443A1
- Authority
- PE
- Peru
- Prior art keywords
- amino
- methyl
- carbonyl
- phenyl
- propanoic acid
- Prior art date
Links
Abstract
SE REFIERE A UN COMPUESTO DE FORMULA (IA), DONDE ANILLO AA Y ANILLO AC SON CADA UNO BENCENO OPCIONALMENTE SUSTITUIDO O HETEROCICLO AROMATICO DE 5-6 MIEMBROS OPCIONALMENTE SUSTITUIDO; ANILLO AB ES HETEROCICLO AROMATICO DE 5 MIEMBROS OPCIONALMENTE SUSTITUIDO; RA3 ES ALQUILO C1-C6; CICLOALQUILO C3-C10; ARILO C6-C14 OPCIONALMENTE SUSTITUIDO, ENTRE OTROS; R14 ES H, ALQUILO C1-C6; RA5 ES -(CH2)3-COORA11, -NRA6-CRA7RA8-CRA9RA10-COORA11; RA6, RA7, RA8, RA9 Y RA11 SON CADA UNO H, ALQUILO C1-C6; RA10 ES H, OH O ALQUIILO C1-C6. SON COMPUESTOS SELECCIONADOS: ACIDO 3-{[(4-{[CICLOHEXIL(3-METIL-1-BENZOFURAN-2-IL)METIL]AMINO}FENIL)CARBONIL](METIL)AMINO}PROPANOICO; ACIDO 3-{[(6-{[CICLOHEXIL(5-FLUORO-3-METIL-1-BENZOFURAN-2-IL)METIL]AMINO}PIRIDIN-3-IL)CARBONIL](METIL)AMINO}PROPANOICO; 3-{[(4-{[2-ETIL-1-(5-FLUORO-3-METIL-1-BENZOFURAN-2-IL)BUTIL]AMINO}FENIL)CARBONIL](METIL)AMINO}PROPANOICO, ENTRE OTROSTAMBIEN SE REFIERE A UN PROCEDIMIENTO Y UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON ANTAGONISTAS DE GLUCAGON SIENDO UTILES EN EL TRATAMIENTO DE DIABETESIT REFERS TO A COMPOUND OF FORMULA (IA), WHERE AA RING AND AC RING ARE EACH ONE OPTIONALLY REPLACED BENZENE OR OPTIONALLY REPLACED 5-6 MEMBER AROMATIC HETEROCYCLE; RING AB IS OPTIONALLY REPLACED 5-MEMBER AROMATIC HETEROCYCLE; RA3 IS C1-C6 ALKYL; C3-C10 CYCLOALKYL; ARILO C6-C14 OPTIONALLY SUBSTITUTED, AMONG OTHERS; R14 IS H, C1-C6 ALKYL; RA5 ES - (CH2) 3-COORA11, -NRA6-CRA7RA8-CRA9RA10-COORA11; RA6, RA7, RA8, RA9 AND RA11 ARE EACH H, C1-C6 ALKYL; RA10 IS H, OH OR C1-C6 ALKYYL. SELECTED COMPOUNDS ARE: 3 - {[(4 - {[CYCLOHEXIL (3-METHYL-1-BENZOFURAN-2-IL) METHYL] AMINO} PHENYL) CARBONYL] (METHYL) AMINO} PROPANOIC ACID; 3 - {[(6 - {[CYCLOHEXIL (5-FLUORO-3-METHYL-1-BENZOFURAN-2-IL) METHYL] AMINO} PYRIDIN-3-IL) CARBONYL] (METHYL) AMINO} PROPANOIC ACID; 3 - {[(4 - {[2-ETHYL-1- (5-FLUORO-3-METHYL-1-BENZOFURAN-2-IL) BUTYL] AMINO} PHENYL) CARBONYL] (METHYL) AMINO} PROPANOIC, BETWEEN OTHERS ALSO SE REFERS TO A PROCEDURE AND A PHARMACEUTICAL COMPOSITION. SAID COMPOUNDS ARE ANTAGONISTS OF GLUCAGON BEING USEFUL IN THE TREATMENT OF DIABETES
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009025511 | 2009-02-06 | ||
PCT/JP2009/054095 WO2009110520A1 (en) | 2008-03-05 | 2009-03-04 | Heterocyclic compound |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20100443A1 true PE20100443A1 (en) | 2010-06-25 |
Family
ID=42561095
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2009001096A PE20100443A1 (en) | 2009-02-06 | 2009-09-02 | DERIVATIVES OF PHENYL-CARBONYL-AMINO-PROPANOIC ACID AS ANTAGONISTS OF GLUCAGON |
Country Status (5)
Country | Link |
---|---|
AR (1) | AR073486A1 (en) |
CL (1) | CL2009001796A1 (en) |
PE (1) | PE20100443A1 (en) |
TW (1) | TWI475018B (en) |
UY (1) | UY32088A (en) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1463715A1 (en) * | 2001-12-03 | 2004-10-06 | Novo Nordisk A/S | Novel glucagon antagonists |
US6881746B2 (en) * | 2001-12-03 | 2005-04-19 | Novo Nordick A/S | Glucagon antagonists/inverse agonists |
US6762318B2 (en) * | 2001-12-03 | 2004-07-13 | Novo Nordisk A/S | Glucagon antagonists |
JP4601611B2 (en) * | 2003-05-01 | 2010-12-22 | ブリストル−マイヤーズ スクイブ カンパニー | Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors |
EP1626717A4 (en) * | 2003-05-09 | 2009-09-09 | Merck & Co Inc | Benzimidazoles, compositions containing such compounds and methods of use |
PT1951661E (en) * | 2005-11-17 | 2012-09-19 | Lilly Co Eli | Glucagon receptor antagonists, preparation and therapeutic uses |
-
2009
- 2009-09-02 UY UY0001032088A patent/UY32088A/en not_active Application Discontinuation
- 2009-09-02 PE PE2009001096A patent/PE20100443A1/en active IP Right Grant
- 2009-09-02 TW TW098129505A patent/TWI475018B/en not_active IP Right Cessation
- 2009-09-02 CL CL2009001796A patent/CL2009001796A1/en unknown
- 2009-09-02 AR ARP090103387A patent/AR073486A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CL2009001796A1 (en) | 2011-09-16 |
TW201029996A (en) | 2010-08-16 |
TWI475018B (en) | 2015-03-01 |
UY32088A (en) | 2010-08-31 |
AR073486A1 (en) | 2010-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY32884A (en) | 1-substituted-4- (5- (phenyl or heteroaryl) methoxy) -pyrimidin-2-yl) piperazines and piperidines | |
CO6321238A2 (en) | HETEROCICLIC COMPOUND WITH GLUCAGON ANTAGONIST ACTION | |
AR116395A2 (en) | 4- {4 - [({[4-CHLORO-3- (TRIFLUOROMETIL) PHENYL] AMINO} CARBONYL) AMINO] -3-FLUOROPHENOXY} -N-METHYLPYRIDIN-2-CARBOXAMIDE, ITS MONOHYDRATE OR SALT IN A HIGH PURITY FORM | |
UY32547A (en) | PIPERIDINS REPLACED AS AN ANTIGONIST OF CCR3 | |
ES2521596T3 (en) | Combination of GlyT1 compound with antipsychotics | |
AR083003A1 (en) | READING REPLACED BY PIPERIDINYL AS MODULATORS OF GPR119 | |
PE20131153A1 (en) | BRUTON TYROSINE KINASE INHIBITORS | |
CL2010001496A1 (en) | Compounds derived from (pyridin- or pyrimidin-) piperidine, gpr119 agonists; pharmaceutical composition; and its use for the treatment of type I diabetes, type II diabetes and related diseases such as metabolic syndrome, dyslipidemia and insulin resistance. | |
NI201300074A (en) | NOVEL DERIVATIVES OF CYCLIC AZABENZIMIDAZOLE USEFUL AS ANTIDIABETIC AGENTS. | |
CL2011001389A1 (en) | Isoxazoline derivative compounds; composition comprising one of the compounds; and use of the compounds in parasite control. | |
PE20151239A1 (en) | DERIVATIVES OF EXENDIN-4 FUNCTIONALIZED | |
PE20141120A1 (en) | HETEROCYCLIC COMPOUNDS | |
EA201170304A1 (en) | GLUOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE ANALOGUES | |
AR086042A1 (en) | USEFUL COMPOUND FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES AND PHARMACEUTICAL COMPOSITION | |
EA201100037A1 (en) | ORGANIC COMPOUNDS | |
ECSP12012293A (en) | CERTAIN AMINO-PYRIMIDINS, COMPOSITION OF THE SAME AND METHODS FOR THE USE OF THE SAME | |
UY33758A (en) | INDANILOXIDIHIDROBENZOFURANILACETIC ACIDS | |
PE20120693A1 (en) | HETEROCYCLES COMPOUNDS AS MODULATORS OF PYRUVATE KINASE M2 (PKM2) | |
EA201170302A1 (en) | PROCESSED ANALOGUES OF GLUEL-DEPENDENT INSULINOTROPIC POLYPETIDE | |
CL2012001171A1 (en) | Process for the preparation of the ester n - [[2 - [[[4 - [[[(hexyloxycarbonyl)] 4-amino] iminomethyl] phenyl] amino] methyl] 1-alkyl-1h-benzimidazol-5-yl] carbonyl] n-2-pyridinyl-ethyl beta-alanine; and one of the intermediate compounds considered. | |
PE20140703A1 (en) | HETEROARYL DERIVATIVES AS MODULATORS OF NACHR ALPHA 7 | |
EA201170305A1 (en) | GLUOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE ANALOGUES (GIP) MODIFIED BY N-END | |
DOP2012000006A (en) | GPR119 AGONIST | |
CL2012000937A1 (en) | Spiro-derived heterocyclic compounds of cyclohexane, hsl inhibitors; preparation procedure; pharmaceutical composition comprising them; use of the compound for the treatment of diabetes, metabolic syndrome, dyslipidemia, atherosclerosis or obesity. | |
AR084011A1 (en) | USEFUL HETEROCICLIC NITROGEN COMPOUNDS FOR THE TREATMENT OF INFECTIONS BY RESPIRATORY SYNCTIAL VIRUS (RSV), PROCESS TO PREPARE THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration |